Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Savior Lifetec Corp (4167) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8123
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Savior Lifetec Corp (SLC) is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients (APIs) and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include imipenem, meropenem, and ertapenem. The company’s imipenem and cilastatin injection are used in treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin and skin structure infections, endocarditis and polymicrobic infections. The company’s product pipeline consists various injections and subcutaneous injections. It operates offices in Zhunan and Tainan, Taiwan. SLC is headquartered in Zhunan, Taiwan.

Savior Lifetec Corp (4167) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Savior Lifetec Raises USD2.2 Million in Public Offering of Shares 11
Savior Lifetec Raises USD16.6 Million in Rights Offering of Shares 12
Savior Lifetec Raises USD12.3 Million in IPO 13
Savior Lifetec Raises USD11 Million in Public Offering of Shares 14
Debt Offering 15
Savior Lifetec to Raise USD23 Million in Public Offering of Bonds 15
Savior Lifetec Corp – Key Competitors 16
Savior Lifetec Corp – Key Employees 17
Savior Lifetec Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Savior Lifetec Raises USD2.2 Million in Public Offering of Shares 11
Savior Lifetec Raises USD16.6 Million in Rights Offering of Shares 12
Savior Lifetec Raises USD12.3 Million in IPO 13
Savior Lifetec Raises USD11 Million in Public Offering of Shares 14
Savior Lifetec to Raise USD23 Million in Public Offering of Bonds 15
Savior Lifetec Corp, Key Competitors 16
Savior Lifetec Corp, Key Employees 17
Savior Lifetec Corp, Other Locations 18

List of Figures
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electricity Generating Public Co Ltd:発電所・企業SWOT分析
    Electricity Generating Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Lansdowne Oil & Gas plc (LOGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Probi AB (PROB):企業の財務・戦略的SWOT分析
    Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MEDICREA Group (ALMED):医療機器:M&Aディール及び事業提携情報
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • Sygnature Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sygnature Discovery Ltd (Sygnature) is a drug discovery company that offers medicinal chemistry, bioscience, computational chemistry, and fragment-based drug discovery programs. The company offers services for various phases of drug discovery which include hit identification, hit to lead, an …
  • Caixa Geral de Depositos SA:企業の戦略的SWOT分析
    Caixa Geral de Depositos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Nanophase Technologies Corp (NANX):企業の財務・戦略的SWOT分析
    Nanophase Technologies Corp (NANX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • WEC Energy Group:企業の戦略・SWOT・財務分析
    WEC Energy Group - Strategy, SWOT and Corporate Finance Report Summary WEC Energy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Central Securities Corp (CET):企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a investment management company. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, warrants, options real estate and …
  • Laboratoires Pierre Fabre SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • University of Toronto-製薬・医療分野:企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • Neurolixis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurolixis Inc (Neurolixis) is an early-stage biopharmaceutical company that discovers and develops novel drugs for the treatment of human central nervous system disorders. The company’s pipeline product portfolio includes NLX-112, a drug candidate intended for the treatment of L-DOPA-induce …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Societe Nationale d’Electrolyse et de Petrochimie SA (SNP):企業の財務・戦略的SWOT分析
    Societe Nationale d'Electrolyse et de Petrochimie SA (SNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compa …
  • Punjab National Bank (PNB):電力:M&Aディール及び事業提携情報
    Summary Punjab National Bank (PNB) offers retail and commercial banking, agricultural and international banking, and other financial services. Its retail and commercial banking portfolio offers credit and debit cards, corporate and retail loans, deposit services, cash management, and export and impo …
  • ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary ConverGene LLC (ConverGene) is a small molecule discovery company that offers development of cancer drugs targeting the root regulatory mechanisms within cancer cells. The company develops small-molecule drugs that aim at bromodomains, a structural feature of proteins, which mediate epigenet …
  • United-Guardian Inc (UG):企業の財務・戦略的SWOT分析
    Summary United-Guardian Inc (United-Guardian) is a diversified company that manufactures and markets healthcare products. The company offers pharmaceuticals, cosmetic ingredients, health care products and proprietary industrial products, among others. It provides medical devices such as hydrajel PL, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆